Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sickle cell disease and stroke.
Verduzco LA, Nathan DG. Verduzco LA, et al. Among authors: nathan dg. Blood. 2009 Dec 10;114(25):5117-25. doi: 10.1182/blood-2009-05-220921. Blood. 2009. PMID: 19797523 Free article. Review.
Targeting iNKT cells for the treatment of sickle cell disease.
Field JJ, Nathan DG, Linden J. Field JJ, et al. Among authors: nathan dg. Clin Immunol. 2011 Aug;140(2):177-83. doi: 10.1016/j.clim.2011.03.002. Epub 2011 Mar 22. Clin Immunol. 2011. PMID: 21429807 Free PMC article. Review.
Sickle cell disease (SCD), iNKT cells, and regadenoson infusion.
Nathan DG, Field J, Lin G, Neuberg D, Majerus E, Onyekwere O, Keefer J, Okam M, Ross A, Linden J. Nathan DG, et al. Trans Am Clin Climatol Assoc. 2012;123:312-7; discussion 317-8. Trans Am Clin Climatol Assoc. 2012. PMID: 23303999 Free PMC article. Clinical Trial.
The role of adenosine signaling in sickle cell therapeutics.
Field JJ, Nathan DG, Linden J. Field JJ, et al. Among authors: nathan dg. Hematol Oncol Clin North Am. 2014 Apr;28(2):287-99. doi: 10.1016/j.hoc.2013.11.003. Epub 2014 Jan 18. Hematol Oncol Clin North Am. 2014. PMID: 24589267 Free PMC article. Review.
Advances in sickle cell therapies in the hydroxyurea era.
Field JJ, Nathan DG. Field JJ, et al. Among authors: nathan dg. Mol Med. 2014 Dec 16;20 Suppl 1(Suppl 1):S37-42. doi: 10.2119/molmed.2014.00187. Mol Med. 2014. PMID: 25549232 Free PMC article. Review.
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.
Field JJ, Majerus E, Gordeuk VR, Gowhari M, Hoppe C, Heeney MM, Achebe M, George A, Chu H, Sheehan B, Puligandla M, Neuberg D, Lin G, Linden J, Nathan DG. Field JJ, et al. Among authors: nathan dg. Blood Adv. 2017 Aug 28;1(20):1645-1649. doi: 10.1182/bloodadvances.2017009613. eCollection 2017 Sep 12. Blood Adv. 2017. PMID: 29296811 Free PMC article.
387 results